NO304260B1 - Tablett for programmert avgivelse av naproksen - Google Patents

Tablett for programmert avgivelse av naproksen

Info

Publication number
NO304260B1
NO304260B1 NO933177A NO933177A NO304260B1 NO 304260 B1 NO304260 B1 NO 304260B1 NO 933177 A NO933177 A NO 933177A NO 933177 A NO933177 A NO 933177A NO 304260 B1 NO304260 B1 NO 304260B1
Authority
NO
Norway
Prior art keywords
naproxen
released
therapeutic
tablet
tablets
Prior art date
Application number
NO933177A
Other languages
English (en)
Norwegian (no)
Other versions
NO933177L (no
NO933177D0 (no
Inventor
Egidio Marchi
Leone Gabriele Rotini
Original Assignee
Alfa Wassermann Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfa Wassermann Spa filed Critical Alfa Wassermann Spa
Publication of NO933177D0 publication Critical patent/NO933177D0/no
Publication of NO933177L publication Critical patent/NO933177L/no
Publication of NO304260B1 publication Critical patent/NO304260B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
NO933177A 1992-09-11 1993-09-07 Tablett for programmert avgivelse av naproksen NO304260B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITBO920315A IT1258143B (it) 1992-09-11 1992-09-11 Compresse a cessione programmata contenenti naproxen

Publications (3)

Publication Number Publication Date
NO933177D0 NO933177D0 (no) 1993-09-07
NO933177L NO933177L (no) 1994-03-14
NO304260B1 true NO304260B1 (no) 1998-11-23

Family

ID=11338458

Family Applications (1)

Application Number Title Priority Date Filing Date
NO933177A NO304260B1 (no) 1992-09-11 1993-09-07 Tablett for programmert avgivelse av naproksen

Country Status (20)

Country Link
US (1) US5480650A (fr)
EP (1) EP0587065B1 (fr)
KR (1) KR970008157B1 (fr)
CN (1) CN1088091A (fr)
AT (1) ATE148340T1 (fr)
AU (1) AU669552B2 (fr)
CA (1) CA2105541C (fr)
CZ (1) CZ279853B6 (fr)
DE (1) DE69307807T2 (fr)
DK (1) DK0587065T3 (fr)
ES (1) ES2097952T3 (fr)
FI (1) FI933975L (fr)
GR (1) GR3022434T3 (fr)
IL (1) IL106943A (fr)
IS (1) IS1624B (fr)
IT (1) IT1258143B (fr)
MX (1) MX9305445A (fr)
NO (1) NO304260B1 (fr)
NZ (1) NZ248574A (fr)
ZA (1) ZA936445B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5609884A (en) * 1992-08-31 1997-03-11 G. D. Searle & Co. Controlled release naproxen sodium plus naproxen combination tablet
US8022095B2 (en) * 1996-08-16 2011-09-20 Pozen, Inc. Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
US6153225A (en) * 1998-08-13 2000-11-28 Elan Pharma International Limited Injectable formulations of nanoparticulate naproxen
US6165506A (en) * 1998-09-04 2000-12-26 Elan Pharma International Ltd. Solid dose form of nanoparticulate naproxen
CA2394077A1 (fr) * 1999-12-16 2001-06-21 Trident Technologies, Llc Systeme et procede assurant l'apport prolonge d'un agent therapeutique en meme temps que sa dose de mise en charge de recepteur
ES2380827T3 (es) * 2002-12-26 2012-05-18 Pozen, Inc. Formas de dosificación con múltiples capas que contienen naproxeno y triptanes
CA2592605C (fr) 2004-12-27 2010-12-07 Eisai R&D Management Co., Ltd. Methode de stabilisation d'un medicament contre la demence
CN101969931A (zh) * 2008-03-05 2011-02-09 万能药生物有限公司 包含霉酚酸的调节释放药物组合物及其方法
US20090252791A1 (en) * 2008-04-02 2009-10-08 Venkata Nookaraju Sreedharala Pharmaceutical compositions comprising a triptan and a nonsteroidal anti-inflammatory drug
US20090311335A1 (en) * 2008-06-12 2009-12-17 Scott Jenkins Combination of a triptan and an nsaid
AU2009260166B2 (en) * 2008-06-20 2014-10-09 Alphapharm Pty Ltd Pharmaceutical formulation
US10835495B2 (en) 2012-11-14 2020-11-17 W. R. Grace & Co.-Conn. Compositions containing a biologically active material and a non-ordered inorganic oxide material and methods of making and using the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1200178B (it) * 1986-07-23 1989-01-05 Alfa Farmaceutici Spa Formulazioni galeniche a cessione programmata contenenti farmaci ad attivita' antiflogistica
IT1215726B (it) * 1988-01-18 1990-02-22 Alfa Wassermann Spa Formulazioni galeniche a cessione programmata.
US5232705A (en) * 1990-08-31 1993-08-03 Alza Corporation Dosage form for time-varying patterns of drug delivery
US5204116A (en) * 1991-05-01 1993-04-20 Alza Corporation Dosage form providing immediate therapy followed by prolonged therapy

Also Published As

Publication number Publication date
AU669552B2 (en) 1996-06-13
DE69307807D1 (de) 1997-03-13
FI933975A0 (fi) 1993-09-10
ZA936445B (en) 1995-01-31
NO933177L (no) 1994-03-14
EP0587065B1 (fr) 1997-01-29
CA2105541A1 (fr) 1994-03-12
KR940006577A (ko) 1994-04-25
ITBO920315A1 (it) 1994-03-11
FI933975A7 (fi) 1994-03-12
CZ279853B6 (cs) 1995-07-12
CN1088091A (zh) 1994-06-22
FI933975L (fi) 1994-03-12
KR970008157B1 (ko) 1997-05-21
IS1624B (is) 1996-10-18
ATE148340T1 (de) 1997-02-15
CA2105541C (fr) 1999-01-05
IL106943A (en) 1998-09-24
ITBO920315A0 (it) 1992-09-11
EP0587065A1 (fr) 1994-03-16
US5480650A (en) 1996-01-02
AU4620293A (en) 1994-03-17
CZ180693A3 (en) 1994-03-16
ES2097952T3 (es) 1997-04-16
DE69307807T2 (de) 1997-05-15
IS4069A (is) 1994-03-12
GR3022434T3 (en) 1997-04-30
IT1258143B (it) 1996-02-20
MX9305445A (es) 1994-05-31
DK0587065T3 (da) 1997-06-09
NZ248574A (en) 1995-04-27
NO933177D0 (no) 1993-09-07

Similar Documents

Publication Publication Date Title
RU98111594A (ru) Фармацевтические композиции, включающие флурбипрофен
NO890194L (no) Galenisk middel.
NO20022014D0 (no) Kontrollert frigjöring av hydrocodone formuleringer
EP0418596A3 (en) Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form
FI873225A0 (fi) Menetelmä suun kautta annettavan galeenisen naprokseenikoostumuksen valmistamiseksi, josta aktiiviyhdiste vapautuu ohjelmoidusti
IL78826A0 (en) Sustained release pharmaceutical compositions incorporating degradable delivery system of drugs
CA2029046A1 (fr) Compositions/dispositifs a distribution continue pour le traitement des maladies periodontiques
DK0600079T3 (da) Oral 1alpha-hydroxyprævitamin D
NO933177D0 (no) Tablett for programmert avgivelse av naproksen
EP0438147A3 (en) Pharmaceutical compositions and dosage forms for the oral administration of calcitonin
DE69803670D1 (de) Tiagabinhaltige arzneizubereitungen mit gesteuerter wirkstoffverabreichung
DE68907091D1 (de) Scleroglucan und wirkstoff enthaltende pharmazeutische tabletten und kapselgranulate.
RU96123569A (ru) Лекарственный препарат
IT1270592B (it) Formulazione a rilascio modificato per la somministrazione di farmaci antiinfiammatori non steroidei

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN MARCH 2001